The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRHI Magnesita Regulatory News (RHIM)

Share Price Information for RHI Magnesita (RHIM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,735.00
Bid: 3,775.00
Ask: 3,790.00
Change: -50.00 (-1.32%)
Spread: 15.00 (0.397%)
Open: 3,820.00
High: 3,820.00
Low: 3,735.00
Prev. Close: 3,785.00
RHIM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q1 2023 Trading Update

5 May 2023 07:00

RNS Number : 5012Y
RHI Magnesita N.V.
05 May 2023
 

RHI Magnesita N.V.

("RHI Magnesita" the "Company" or the "Group")

Q1 2023 TRADING UPDATE

 

RHI Magnesita, the leading global supplier of high‐grade refractory products, systems and solutions, today provides an update on trading for the three months to 31 March 2023 ('Q1').

Q1 trading

The momentum of improving EBITA and EBITA margins established in 2022 continued through the first quarter as lower cost inflation offset an expected reduction in sales volumes.

Refractory sales volumes in the first quarter were 8% lower than Q1 2022, in line with management expectations and overall market demand. As anticipated, steel and cement demand outside of India and China softened due to a slowdown in construction activity, whilst demand in the Industrial Projects segment remained strong.

Prices of magnesite-based raw materials remained at relatively low levels throughout Q1, with the Group's vertical integration margin remaining largely unchanged from the low level of H2 2022.

Refractory margins were resilient due to slower cost escalation, based on lower freight and purchased raw material costs, despite higher energy costs. Profitability was supported by the benefits of the Group's strategic sales and cost reduction initiatives, the contribution from recent acquisitions in Türkiye and India, together with geographic and product diversification. EBITA margins in Q1 were ahead of guidance of approximately 10% for 2023 but pricing pressure is anticipated in the remainder of the year as input costs reduce for refractory producers globally.

Financial position

Net debt to EBITDA reduced to 2.2x after the successful placing on 5 April of 15.7 million new shares in RHI Magnesita India Ltd, to raise €101 million via a Qualified Institutional Placement ("QIP") in India. Including a 12-month historic pro forma EBITDA contribution from businesses acquired during the period and the proceeds of the QIP, pro forma leverage was 2.1x EBITDA.

The Group was able to reduce gearing due to strong operating cash flows and through the proceeds of the QIP, whilst continuing to execute on its inorganic growth strategy. Total investments in M&A of €155 million were completed during Q1 2023, including the acquisitions of the Indian refractory business of Dalmia Bharat Refractories Limited and Hi-Tech Chemicals Limited, and a €5 million investment in MCi Carbon, Australia.

Working capital levels were broadly unchanged from 31 December 2022 as the Group continues to prioritise security of supply for its customers in order to support recent market share gains.

The Group continues to retain robust liquidity of approximately €1.2 billion. This follows the April 2023 placement of €170 million of ESG-linked Schuldschein bonds and the refinancing of a €150 million Term Loan with UniCredit Bank Austria AG. The Term Loan was increased in size from its previous level of €115 million, extended to 2026 and is also now ESG-linked. Both sources of funding were secured at competitive rates of interest.

M&A progress

The acquisitions of Dalmia OCL and Hi-Tech completed in India during Q1 increased the Group's local market share from around 20% to 30% and represent significant progress in the strategic goal to grow in markets in which the Group is under-represented, including in India, China and Türkiye. The Group has now secured new production capacity and a geographically distributed plant network in India, which is expected to be the highest growth refractory market globally. RHI Magnesita will now also be able to supply products more competitively throughout India from low-cost local facilities, as well as pursuing export opportunities in the West Asia and Africa regions. Margins in the India business unit are expected to be diluted during the integration phase as synergies ramp up and market demand grows to fully utilise the newly acquired plant capacity.

The acquisition of a 65% stake in Jinan New Emei, China for a cash consideration of €40 million was agreed on 13 January and completed on 28 April 2023. The acquisition of Dalmia GSB Refractories, Germany for a cash consideration €13 million was agreed on 29 March and completed on 28 April 2023.

On 21 April 2023, the Group announced the acquisition of Seven Refractories for a cash consideration of €93 million, with completion expected in the second half of 2023.

The M&A pipeline remains robust as the Group continues to demonstrate momentum and leadership in the ongoing consolidation of the refractory industry, in markets and products where the Group is under-represented.

Outlook

Order book trends suggest the potential for a gradual recovery in steel customer demand in the short term, although the outlook for end markets and customer volumes remains uncertain and a significant recovery in volumes is not expected, in line with most economic forecasts globally.

On the basis that customer demand continues to recover over the coming months and if pressure on pricing is limited to the passing on of cost normalisation, the Board is confident in the Group's ability to achieve its current guidance for FY 2023.

Leverage measured as a ratio of net debt to EBITDA is expected to remain above 2.0x as the Group further executes on its M&A pipeline.

 

Stefan Borgas, Chief Executive Officer, said: "RHI Magnesita benefited from resilient pricing in the first quarter as we fulfilled orders placed in Q4 2022 during the peak inflationary period. Our improved refractory-margin performance benefits from the investments we have made to rationalize our network and leaves us well placed to meet expectations for the year. Signs of a recovery in short-term demand are visible in our order book and whilst our industry remains exposed to volatility in end markets, we still assume that no major recession will occur globally. We have continued to make steady progress in M&A as we identify value-adding opportunities to grow our business through consolidation in key target geographies and product areas, whilst carefully managing our balance sheet."

 

Conference Call

A conference call will be hosted at 8:15am UK time to discuss the trading update:

Dial in

+44 203 936 2999 or 0800 358 1035 (UK only)

Access code

328251

Webcast and playback facility

LINK

 

 

 

For further enquiries, please contact:

Chris Bucknall, Head of Investor Relations

Tel +43 699 1870 6490

E‐mail: chris.bucknall@rhimagnesita.com

 

About RHI Magnesita

RHI Magnesita is the leading global supplier of high-grade refractory products, systems and solutions which are critical for high-temperature processes exceeding 1,200°C in a wide range of industries, including steel, cement, non-ferrous metals and glass. With a vertically integrated value chain, from raw materials to refractory products and full performance-based solutions, RHI Magnesita serves customers around the world, with around 13,500 employees in 33 main production sites and more than 70 sales offices. RHI Magnesita intends to leverage its leadership in terms of revenue, scale, product portfolio and diversified geographic presence to target strategically those countries and regions benefitting from more dynamic economic growth prospects.

The Group maintains a premium listing on the Official list of the London Stock Exchange (symbol: RHIM) and is a constituent of the FTSE 250 index, with a secondary listing on the prime segment of the Vienna Stock Exchange (Wiener Börse). For more information please visit: www.rhimagnesita.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTAIMMTMTMMTRJ
Date   Source Headline
13th Aug 20196:00 pmRNSTransaction in Own Shares
13th Aug 20197:00 amRNSInterim dividend - Correction of record date
12th Aug 20196:00 pmRNSTransaction in Own Shares
12th Aug 20197:05 amRNSPurchase of own shares
12th Aug 20197:00 amRNSHalf-year Report
12th Jul 20195:35 pmRNSNotice of Results
9th Jul 201910:46 amRNSExternal Directorship
9th Jul 20197:00 amRNSResult of Secondary Placing in RHI Magnesita N.V.
8th Jul 20194:37 pmRNSProposed Secondary Placing in RHI Magnesita N.V.
6th Jun 20193:22 pmRNSResult of AGM
8th May 20197:00 amRNSQ1 2019 TRADING UPDATE
7th May 20199:29 amRNSExternal Directorship
1st May 20196:00 pmRNSTotal Voting Rights
18th Apr 201912:08 pmRNSExternal Directorship
10th Apr 201911:20 amRNSMerger Update
1st Apr 201910:37 amRNSTotal Voting Rights
27th Mar 20199:34 amRNSSecondary listing on Vienna Stock Exchange
27th Mar 20197:00 amRNSFinal Results
20th Mar 201910:04 amRNSMerger Update
6th Mar 201910:27 amRNSNotice of Results
28th Feb 20194:03 pmRNSTotal Voting Rights
21st Feb 201910:35 amRNSMerger Update
14th Feb 20196:12 pmRNSNotification of Agreement
31st Jan 20195:44 pmRNSTotal Voting Rights
25th Jan 20196:00 pmRNSRHI Magnesita
24th Jan 20197:00 amRNSCancellation of Listing
22nd Jan 201911:36 amRNSMerger Update
22nd Jan 201911:21 amRNSResignation of Director
10th Jan 201912:18 pmRNSDirectorate Change
2nd Jan 20197:00 amRNSTotal Voting Rights
17th Dec 201812:16 pmRNSAdditional Listing
12th Dec 20185:46 pmRNSRHI Magnesita
12th Dec 20184:45 pmRNSDirector/PDMR Shareholding
11th Dec 201812:23 pmRNSBlock Listing Application
11th Dec 20187:00 amRNSMerger Update
3rd Dec 201810:12 amRNSDirector/PDMR Shareholding
28th Nov 20187:00 amRNSDirectorate Change
28th Nov 20187:00 amRNSSite Visit Presentation
27th Nov 20185:50 pmRNSDirector/PDMR Shareholding
12th Nov 20187:00 amRNSMerger Update
5th Nov 20187:01 amRNS3rd Quarter Results
2nd Nov 201811:29 amRNSChange of Corporate Broker
21st Sep 201811:21 amRNSUpdate on position of Chief Financial Officer
16th Aug 20187:00 amRNSHalf-year Report
6th Aug 20187:00 amRNSNew Term Loan and Multi-currency Credit Facility
1st Aug 20189:07 amRNSNotification under Listing Rule 9.6.14R
1st Aug 20187:00 amRNSProposed merger of Indian subsidiaries
29th Jun 20182:46 pmRNSDirector/PDMR Shareholding
29th Jun 20182:43 pmRNSDirector/PDMR Shareholding
29th Jun 20182:42 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.